Mr Majid Alhomrani
Cirrhosis is the end-stage of liver fibrosis characterised by replacement of normal liver tissue into scar tissue. The only treatment options available for cirrhosis patients is liver transplantation. Here we provide a robust data suggesting that human amnion epithelial cells (hAECs) derived exosome (cell-free therapy) could reverse established liver fibrosis and reduce liver inflammation despite the ongoing damage.
Liver/Gut Inflammation and Fibrosis-SCS and Amnion Cell Biology-TRC
Journal and article title
Exosome derived from hAECs had similar therapeutic effects to hAECs in chronic liver fibrosis. The exosome is a promising cell-free therapy for chronic liver injury.